Lavo Life Sciences LLC
AI-accelerated quantum chemistry for drug development
Atlanta, United States · Founded 2023 · $1.5M raised
- Headquarters
- Atlanta, Georgia
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- lavo.ai
- Total Funding
- $1.5M
About
Lavo Life Sciences develops AI-powered software that simulates drug behavior at the atomic scale using physics-based machine learning. Its platform predicts crystal structures of small drug molecules to help pharmaceutical companies develop more effective formulations faster. The company is a Y Combinator-backed startup and NSF SBIR Phase II awardee.
Summary
Lavo Life Sciences LLC is an Artificial Intelligence company based in Atlanta, United States, founded in 2023. It has raised $1.5M in total.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company